Get a reply from this employer
Your resume and cover letter, tailored to exactly what they’re hiring for.
The Centre for Genomic Regulation (CRG) in Barcelona invites applications for a postdoctoral researcher to lead the discovery of genetic mechanisms of diabetes in large whole-genome sequencing cohorts. The role involves analyzing datasets and applying advanced genomic tools to interpret non-coding variation in human disease.
Join the CRG, a premier biomedical research institute, and collaborate with experts across computational biology, human genetics, and machine learning to drive mechanistic
The Centre for Genomic Regulation (CRG) is an international biomedical research institute of excellence, based in Barcelona, Spain, with more than 400 scientists from 44 countries. The CRG is composed by an interdisciplinary, motivated and creative scientific team that is supported both by a flexible and efficient administration and by high-end and innovative technologies.
In September 2026, the Centre for Genomic Regulation (CRG) received the renewal of the 'HR Excellence in Research' Award from the European Commission. This is a recognition of the Institute's commitment to developing an HR Strategy for Researchers, designed to bring the practices and procedures in line with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment of Researchers (Charter and Code).
Please, check out our Recruitment Policy
We are looking for a postdoctoral researcher to lead the discovery of new genetic mechanisms of diabetes in two large whole-genome sequencing cohorts led by the host lab. The first comprises more than 1,300 index patients with a presumptive diagnosis of orphan monogenic diabetes; the second, assembled through the Spanish IMPACT-T2D consortium, comprises more than 1,000 patients with early-onset, non-obese type 2 diabetes. Together they offer an opportunity to find new causal variation mechanisms of disease, including non-coding genome defects.
The post will entail leading analysis of these datasets, working alongside colleagues who develop and apply advanced genomic tools to interpret the functional consequences of non-coding variation in human disease, providing opportunities to take findings through to mechanism.
The laboratory in the Computational Biology and Health Genomics programme at CRG, in a collaborative environment with computational, human genetics, single-cell genomics and machine learning groups.
The lab combines genetics and genomics to understand how pancreatic β cells are programmed, and uses that knowledge to open therapeutic avenues. Recent work from the lab includes the discovery of a β-cell transcription–splicing axis driven by HNF1A, showing how a gene mutated in monogenic diabetes also plays a key role in polygenic type 2 diabetes (Bernardo et al., Cell Metab 2025). In related work the team uncovered a lncRNA promoter that acts as a cis-regulatory element to dial the transcription of HNF1A, and thereby safeguards the fidelity of a cell-specific transcription factor program (Beucher et al., Nat Cell Biol 2022; Ferrer, Nat Rev Mol Cell Biol 2024). Using mouse and human models, the team showed how point mutations in a single enhancer cause a severe pancreatic developmental defect (Miguel-Escalada et al., Dev Cell 2022).
We provide a highly stimulating environment with state-of-the-art infrastructures, and unique professional career development opportunities. To check out our training and development portfolio, please visit our website in the training section.
We offer and promote a diverse and inclusive environment and welcomes applicants regardless of age, disability, gender, nationality, ethnicity, religion, sexual orientation or gender identity.
The CRG is committed to reconcile a work and family life of its employees and are offering extended vacation period and the possibility to benefit from flexible working hours.
This position is supported by the AXA Research Fund through the AXA Chair in Risk Prediction in Age-Related Diseases